I think the key is proactive planning and continuous monitoring. First, identify tasks on the critical path since they have zero float and identify the highest schedule risk. For these tasks, build in contingency buffers and closely track progress through…   Read more»

I think the ideal and best answer is a balance of both but it really depends on the phase and complexity of the project. In medical device development for example, certain roles require specialized expertise such as regulatory affairs, quality…   Read more»

If I were halfway through a project and noticed that both the Schedule Variance (SV) and Cost Variance (CV) were negative, I would first focus on understanding the root cause before reacting. Being behind schedule and over budget does not…   Read more»

I do not believe penalties should be automatic. Accountability is important but the response should definitely depend on the root cause. If overruns are from uncontrollable factors or approved scope changes, the focus should be on improving risk management and…   Read more»

When personal issues arise between team members, I believe the project manager’s role is to protect both the team dynamic and the project objectives without becoming personally involved in the conflict. My approach would start with remaining neutral and strictly…   Read more»

One way to avoid this situation is by implementing a formal version control system with a single source of truth such as a shared drive with controlled access, PLM system, or at minimum clearly labeled revision numbers with approval dates….   Read more»

Verification failure can be one of the most stressful phases of a project because it exposes gaps between the intended design and real world performance. From a project management perspective, I think formal tools like 5 Whys, fishbone diagrams, and…   Read more»

A project manager can align business needs with customer satisfaction by defining value from both perspectives at the start of the project. This is the key. It is not just about meeting scope and deadlines, but about understanding what success…   Read more»

One way is to tie reporting directly to value, not compliance. When team members see that their updates actually influence decisions such as workload balancing, removing blockers, or adjusting sprint priorities, they are more likely to engage. This is great…   Read more»

I think the main reason DID and DSD are kept separate is clarity and traceability. The DID defines what the device must do based on user, clinical, and regulatory needs. The DSD defines how the design meets those needs in…   Read more»

One major issue is regulatory noncompliance. Each device class (I, II, III) has different FDA requirements for testing, documentation, and approval pathways such as 510(k) and PMA pathway. If a device is classified too low, it may bypass necessary preclinical…   Read more»

I believe that projects are most effective when roles are clearly defined and a single team lead is established. Without clear ownership of tasks, groups often struggle with duplicated work, missed responsibilities, and confusion over who is accountable when decisions…   Read more»

I have  worked in both small and large teams, and found that team size really changes how decisions get made. Personally, I prefer smaller teams (3-6 people) for most projects. Communication is faster, roles are clearer, and it is easier…   Read more»

If I were a project manager and my team was falling behind due to conflict, my first step would be to address the issue early and directly rather than letting it escalate. I would start by speaking with the team…   Read more»

One key way to communicate effectively in a project team is clarity and structure. Setting clear expectations early such as roles, responsibilities, deadlines, and preferred communication channels will help reduce confusion. When everyone knows who is responsible for what and…   Read more»

To me, the biggest challenge in managing medical device projects is not just any single factor like regulation or technology, but aligning all of them simultaneously while requirements keep evolving. Regulatory hurdles are definitely significant, but what makes them especially…   Read more»

I am pretty aligned with your take that leadership is mostly nurtured rather than something people are simply born with. While some individuals may naturally have traits like confidence, charisma, or decisiveness, those traits alone do not automatically make someone…   Read more»

Risk acceptance does always involve acknowledging a higher probability of harm compared to avoidance or mitigation, but it does not mean the decision is careless or unsafe. In medical device development, risk is only accepted when it has been reduced…   Read more»

In medical device development, true zero risk is essentially impossible, especially for implantable or life sustaining products. Even with extensive verification, validation, and post-market monitoring, there will always be some residual risk that can not be engineered away. This failure…   Read more»

A medical device’s risk profile is shaped by several key characteristics, including the severity of harm if something goes wrong, the likelihood that a failure or misuse will occur, and how easily that failure can be detected before it causes…   Read more»